We are live on ! Find out more
RBC

Romano Brothers & Co Portfolio holdings

AUM $994M
1-Year Est. Return 41.36%
This Fund
S&P 500
This Quarter Est. Return
+0.34%
1 Year Est. Return
+41.36%
3 Year Est. Return
+100.69%
5 Year Est. Return
10 Year Est. Return
AUM
$792M
AUM Growth
-$10.5M
Cap. Flow
-$2.57M
Cap. Flow %
-0.32%
Top 10 Hldgs %
25.53%
Holding
314
New
4
Increased
54
Reduced
159
Closed
12

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$2.81M
2
PEP icon
PepsiCo
PEP
+$2.48M
3
LRCX icon
Lam Research
LRCX
+$2.14M
4
CON
Concentra Group Holdings
CON
+$1.27M
5
GPC icon
Genuine Parts
GPC
+$1.15M

Top Sells

Rank Stock Value
1
IP icon
International Paper
IP
+$2.28M
2
CVS icon
CVS Health
CVS
+$1.59M
3
SEM
Select Medical
SEM
+$1.26M
4
INTC icon
Intel
INTC
+$848K
5
SWK icon
Stanley Black & Decker
SWK
+$705K

Sector Composition

Rank Sector Weight
1 Technology 23.06%
2 Industrials 12.82%
3 Healthcare 11.96%
4 Financials 8.77%
5 Consumer Discretionary 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MET icon
51
MetLife
MET
$61.9B
$4.42M 0.56%
53,984
-530
-1% -$44.1K
AEP icon
52
American Electric Power
AEP
$69.6B
$4.36M 0.55%
47,270
-400
-0.8% -$38.7K
CB icon
53
Chubb
CB
$135B
$4.29M 0.54%
15,539
-395
-2% -$112K
LLY icon
54
Eli Lilly
LLY
$1.02T
$4.26M 0.54%
5,519
-7
-0.1% -$5.8K
WM icon
55
Waste Management
WM
$90.6B
$4.26M 0.54%
21,103
-130
-0.6% -$27.9K
T icon
56
AT&T
T
$159B
$4.22M 0.53%
185,435
-1,634
-0.9% -$36.8K
BMY icon
57
Bristol-Myers Squibb
BMY
$133B
$4.21M 0.53%
74,348
-6,801
-8% -$380K
PG icon
58
Procter & Gamble
PG
$336B
$4.07M 0.51%
24,276
-1,992
-8% -$339K
IVV icon
59
iShares Core S&P 500 ETF
IVV
$878B
$3.99M 0.5%
6,773
+192
+3% +$114K
C icon
60
Citigroup
C
$222B
$3.97M 0.5%
56,458
+2,805
+5% +$189K
TRV icon
61
Travelers Companies
TRV
$78.1B
$3.74M 0.47%
15,530
+15
+0.1% +$3.75K
CNC icon
62
Centene
CNC
$30.7B
$3.71M 0.47%
61,185
-570
-0.9% -$35.5K
DE icon
63
Deere & Co
DE
$160B
$3.67M 0.46%
8,664
-46
-0.5% -$19.4K
ENB icon
64
Enbridge
ENB
$119B
$3.67M 0.46%
86,429
CMI icon
65
Cummins
CMI
$87.5B
$3.61M 0.46%
10,363
-49
-0.5% -$17.2K
LHX icon
66
L3Harris
LHX
$51.6B
$3.45M 0.44%
16,429
-200
-1% -$47.9K
MDY icon
67
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
$3.41M 0.43%
5,982
CVS icon
68
CVS Health
CVS
$133B
$3.38M 0.43%
75,329
-28,288
-27% -$1.59M
MMM icon
69
3M
MMM
$90.9B
$3.37M 0.43%
26,136
TXN icon
70
Texas Instruments
TXN
$252B
$3.3M 0.42%
17,603
-425
-2% -$84.9K
EMN icon
71
Eastman Chemical
EMN
$8B
$3.26M 0.41%
35,652
-200
-0.6% -$20.5K
MCD icon
72
McDonald's
MCD
$192B
$3.23M 0.41%
11,137
-100
-0.9% -$29.8K
LH icon
73
Labcorp
LH
$25B
$3.22M 0.41%
14,043
-20
-0.1% -$4.59K
BDX icon
74
Becton Dickinson
BDX
$45.6B
$3.21M 0.41%
14,162
+12,186
+617% +$2.81M
WELL icon
75
Welltower
WELL
$169B
$3.21M 0.4%
25,453
-600
-2% -$78.8K

Similar funds

Romano Brothers & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Romano Brothers & Co held 314 positions worth $792M, down 1.3% from $803M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Romano Brothers & Co's Q4 2024 filing shows 4 new, 54 increased, 159 reduced and 12 closed positions. Its largest new stake was Lam Research: 28,185 shares worth $2.04M. The largest sale was International Paper, an estimated $2.28M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Industrials and Healthcare.

  • Romano Brothers & Co's largest Q4 2024 buy was Lam Research: 28,185 shares worth $2.04M.
  • Romano Brothers & Co added most to Becton Dickinson in Q4 2024, an estimated $2.81M increase.
  • Romano Brothers & Co's biggest Q4 2024 reduction was International Paper, cutting an estimated $2.28M.
  • Romano Brothers & Co fully exited DuPont de Nemours in Q4 2024, selling an estimated $307K.
  • Romano Brothers & Co's ten largest holdings make up 26% of its $792M portfolio in Q4 2024.
  • Romano Brothers & Co opened 4 new positions and closed 12 in Q4 2024.
  • Romano Brothers & Co's portfolio value fell 1.3% quarter-over-quarter to $792M.

Based on Romano Brothers & Co's 13F filing for Q4 2024, filed 16 Jan 2025.